Point/Counterpoint: The Case for Eli Lilly

ETFs Focus on China Consumer Companies Eyeing Future Growth

VIEW IN BROWSER

📚 Weekend Reads | Sunday, Nov 1, 2020

Point/Counterpoint: The Case for Eli Lilly

Eli Lilly disappointed investors with its third-quarter earnings report on Tuesday but despite that it may be worth it for long-term investors to consider buying shares of the drugmaker, particularly at current levels. Investing.com's Christiana Sciaudone argues the bull case for Eli Lilly, while Geoffrey Smith explains why there are better value stocks to buy now. This is Point/Counterpoint.

Read Full Article

Most Popular Analysis

ETFs Focus on China Consumer Companies Eyeing Future Growth By Investing.com The U.S.-China trade war doesn't much scare off Danton Goei. The portfolio manager for the Davis Funds sees Chinese consumer companies growing regardless of tariffs as the population urbanizes.

CVS Mask Sales Mean Booming Revenue for Young Boomer By Investing.com Boomer Naturals started out in 2019 making healthy living products that provided the same treatment as CBD products, without the marijuana.

Buckle Up, The Ride May Get Bumpy For Investors By Marc Chandler The week ahead would have been daunting for investors in any...

Market Drops As Traders Head For The Pre-Election Exit By Lance Roberts We have discussed how the markets drifted from one stimulus...

Managing Trading Risks: From Irrational Exuberance To Dramatic Reversals By Victor Adair There was a very important Key Turn Date (KTD) at the beginning of September when several different market trends all REVERSED direction at the same time. Those reversals set up the market for the...

Show More Analysis »

Weekly Comic

Political Uncertainty Hits Financial Markets With Just A Few Days To Go Until The U.S. Election

Show More Comics »

Download Our Award Winning Apps

Follow us:

To ensure proper delivery of Investing.com Newsletters to your inbox, please add newsletter@investingmail.com to your safe sender list.

Disclaimer: Fusion Media or anyone involved with Fusion Media will not accept any liability for any trading loss or damage as a result of reliance on the information contained within this email including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Fusion Media would like to remind you that the data contained in this email is neither necessarily real-time nor accurate. All stock prices, Indexes, Futures, buy/sell Signals and Forex prices are indicative and not appropriate for trading purposes; furthermore they are not provided by an exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price. Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. This is a newsletter from Investing.com © 2007-2020 Fusion Media Limited. All Rights Reserved 7 Florinis Street, Greg Tower 6th Floor Nicosia 1065 Cyprus Terms And Conditions   |   Privacy Policy   |   Manage your e-mail preferences   |   Unsubscribe This email was sent to o354397655@gmail.com